Bruce C. Conway

Director/Board Member presso Trigemina, Inc.

72 anni

Health Technology

Electronic Technology

Profilo

Bruce C.
Conway is currently a Director at Trigemina, Inc. He was previously a Director at Whitehall Corp.
and an Independent Director at Clearpoint Neuro, Inc. from 2011 to 2013.

Posizioni attive di Bruce C. Conway

Società	Posizione	Inizio
Trigemina, Inc. Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.	Director/Board Member	-

Tutte le posizioni attive di Bruce C. Conway

Precedenti posizioni note di Bruce C. Conway

Società	Posizione	Fine
CLEARPOINT NEURO, INC.	Director/Board Member	12/04/2013
Whitehall Corp. Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million.	Director/Board Member	-

Vedi nel dettaglio l'esperienza di Bruce C. Conway

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bruce C. Conway

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CLEARPOINT NEURO, INC.	Health Technology

Aziende private	2
Whitehall Corp. Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million.	Electronic Technology
Trigemina, Inc. Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.	Health Technology